Donepezil reverses buprenorphine-induced central respiratory depression in anesthetized rabbits

par SAKURABA,SHIGEKI, TSUJITA,MIKI, ARISAKA,HIROFUMI, TAKEDA,JUNZO, YOSHIDA,KAZUICHI, KUWANA,SHUN-ICHI
Publié 2009

Association between Participation in Counseling and Retention in a Buprenorphine-Assisted Treatment Program for People Experiencing Homelessness with Opioid Use Disorder

par Amanda R. W. Berry, Tracy L. Finlayson, Luke M. Mellis, Lianne A. Urada
Publié 2021

Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records

par Ker S, Hsu J, Balani A, Mukherjee SS, Rush AJ, Khan M, Elchehabi S, Huffhines S, DeMoss D, Rentería ME, Sarkar J
Publié 2021

A Comparative Study between Analgesic Efficacy of Intrathecal Buprenorphine and USG-Guided Transversus Abdominis Plane Block in Patients Undergoing Cesarean Section under Spinal An...

par Rajashree Deelip Godbole, Abhilash Bandari, Jasmeet Gill, Shruti Tolambia, Yuvraj Hake, Pratima Nagare
Publié 2021

Effects of Buprenorphine on the Memory and Learning Deficit Induced by Methamphetamine Administration in Male Rats

par Farshid Etaee, Farshid Etaee, Arezoo Rezvani-Kamran, Somayeh Komaki, Masoumeh Asadbegi, Nafiseh Faraji, Safoura Raoufi, Mohammad Taheri, Masoumeh Kourosh-Arami, Alireza Komaki
Publié 2021

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review

par Michael Soyka
Publié 2021

Rural community pharmacist willingness to dispense Suboxone® - A secret shopper investigation in South-Central Appalachia

par Grace Trull, Erin Major, Chase Harless, William Zule, Bayla Ostrach, Delesha Carpenter
Publié 2021

Comparison of spinal analgesia with Lidocaine plus Buprenorphine and Lidocaine alone

par M Rabiei, B Hassan Nasab, P Amri, H Akbari
Publié 2004

Self-Schema, Attachment Style, and Treatment Outcome of Patients in an Opiate Maintenance Treatment Unit

par Emelie Hovelius, Emelie Hovelius, Ellen Lindén, Hans Bengtsson, Anders Håkansson, Anders Håkansson
Publié 2021

A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder

par Alina Cernasev, Kenneth C. Hohmeier, Kelsey Frederick, Hilary Jasmin, Justin Gatwood
Publié 2021

COMPARISON OF ANALGESIA DURATION, NAUSEA AND VOMITING BETWEEN MARCAINE AND BUPRENORPHINE WITH BUPIVACAINE ALONE IN SPINAL ANESTHESIA

par E Alijanpour, O Movagharnejad, F Naziri, SH Seyfi, A Bijani
Publié 2009

Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence

par Alysse Schultheis, Mark Sanchez, Savannah Pedersen, Tassos Kyriakides, Ya-Chi Ho, Yuval Kluger, Sandra A. Springer
Publié 2021

Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report

par Kulaksizoğlu B, Kara H, Bodur B, Kuloğlu M
Publié 2018

Opioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case report

par Scott Hagan, Carol E. Achtmeyer, Carly Hood, Eric J. Hawkins, Emily C. Williams
Publié 2021

Sexual Adverse Effects and Erectile Dysfunction During Buprenorphine/Naloxone Combination Treatment for Opioid Use Disorders

par Bestepe EE, Tunali N, Sarıdoğan GE
Publié 2020

Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)

par Zajecka JM, Stanford AD, Memisoglu A, Martin WF, Pathak S
Publié 2019